Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2005-02-28
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Considering Patient Diet Preferences to Optimize Weight Loss
NCT01152359
Behaviour-focused Personalised Nutrition Intervention
NCT06631469
A Test of Nutritional Interventions to Enhance Weight Loss Maintenance
NCT01065974
Predicting Adherence to a Heart-Healthy Diet in Lean and Obese Individuals
NCT01862796
Piloting a Novel Intuitive Eating Intervention for College Women With Disordered Eating
NCT03612661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific aims:
1. To test whether the initiation of statin therapy increases dietary saturated fat intake among statin naive patients.
2. To determine what role attitudes, beliefs, expectations, motivation, intention and self-efficacy regarding drug or diet therapy may play in observed changes in dietary behavior after starting statin therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Drug and Dietary behavior
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1. Prior CVD (myocardial infarction, angina, angioplasty, stroke, CABG. or arterial bypass surgery)
2. Diabetes patients
3. Psychiatric patients
4. AIDS patients
5. Substance abuse patients
6. Prior cholesterol lowering medication use
7. Inability to complete the interviews
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Weill Medical College of Cornell University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sundar Natarajan, MD, MSc
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Devin Mann, MD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00710
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.